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Background and objectives:  
Bioinformatic analysis and visualization techniques for ‘omics’ data are key tools for understanding 
complex biological systems. They reduce the complexity of data and allow generating hypotheses 
and searching for disease biomarkers. The aim of this work is to analyse the suitability of 
bioinformatic tools to interpret metabolomics datasets of a range of diseases including type 1 and 2 
diabetes and obesity. 
Methodology:  
We examined several disease datasets from metabolomics studies through different bioinformatic 
approaches: metabolic pathways, networks and disease-/functional-based analyses. Then we have 
analysed the accuracy of these tools to identify several traits of the datasets and their suitability to 
perform enrichment analyses 
Results and conclusions:  
The analysis of metabolic pathways, small-scale systems of biochemical reactions and events of 
regulation and signalling, proved to be the most appropriate approach to analyse metabolomics 
datasets. Tools based on KEGG metabolic pathways were the most suitable ones as they allowed us 
examining metabolic alterations in type 1 and 2 diabetes and obesity and formulating hypotheses 
about the physiopathology of these diseases. For instance, alterations in the metabolism of amino 
acids, nitrogen, glutathione, sphingolipids and primary bile acids were revealed in diseased 
conditions. 
The study of altered metabolic pathways allowed us interpreting data from metabolomics studies 
and extracting very valuable information from them that might help identifying disease biomarkers 
and possible metabolic alterations related to diseases. This information could be translated to the 
clinical practice to predict metabolic alterations before the onset of diseases. 
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